Dual Therapy for Myopia Control

• June 4, 2026

The New Rules of Retina Drug Development

In a panel at the Retina Innovation Summit in Montreal, regulatory experts, drug developers, academic advisors, and investors discussed how evolving FDA guidance is reshaping the path from clinical trials to approval.

• by Jim Gallagher, senior managing editor

• July 15, 2026

• 5 min

Symptomatic intraocular pressure dysregulation during clopidogrel exposure after patent foramen ovale closure in a patient with ocular hypertension and angle crowding: a Case Report

• by Faxue Li, Rongbo Yu, Xuan Guo, Wenyi Ji, Qiang Wu

• July 16, 2026

Spatial altitude factors on the association with myopia: a narrative review

• by Jian Huang, Xiaoqiong Li, Shunming Liu, Li Qi, Lei Liu

• July 20, 2026